跳至主要内容
临床试验/IRCT2014042117380N1
IRCT2014042117380N1已完成1 期

The effect of pentoxifylline on improving of anemia hyporesponsive to recombinant human erythropoietin among patients with ESRD on chronic hemodialysis; a randomized, double blind clinical trial

Vice-chancellor for research -Shahid Sadoughi University of Medical Science0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • all patients with chronic hemodialysis who had hemoglobin level less than 11 gr/dL despite receiving 100-200 IU/Kg/W recombinant erythropoietin at least 3 months before starting the study.
  • Exclusion criteria: age< 18 years old; pregnancy; past history of allergy or intolerance to Pentoxiphyllin; the use of hemodialysis catheter in a recent month; paients with active ulcer disease or dyspepsia; major surgery within 3 months ago; blood transfusion in past month; history of myocardial infarction, stroke and brain hemorrhage in 3 months ago; suboptimal dialysis in recent 2 months ( KT/V < 1.2 ); PTH > 300 pg/mL; Iron deficiency ( ferritin level < 100 µg/L or TIBC < 20% ); any hospitalization in past month ; the previous history of hematological problems such as hemoglobinopathies.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for research -Shahid Sadoughi University of Medical Science

相似试验

The effect of pentoxifylline on improving of anemia ... | 临床试验